菲律宾结核病患者中氟喹诺酮耐药率较低：一项全国性调查结果 - Suppr | 超能文献

相似文献

1

Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey.菲律宾结核病患者中氟喹诺酮耐药率较低：一项全国性调查结果

Eur Respir J. 2018 Mar 22;51(3). doi: 10.1183/13993003.02571-2017. Print 2018 Mar.

2

Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study.耐药性肺结核中氟喹诺酮类耐药的风险评估与传播：一项回顾性基因组流行病学研究。

Sci Rep. 2024 Aug 24;14(1):19719. doi: 10.1038/s41598-024-70535-y.

3

Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.泰国分离出的耐多药结核菌株的二线药物敏感性：最新情况

Int J Tuberc Lung Dis. 2014 Aug;18(8):961-3. doi: 10.5588/ijtld.13.0197.

4

Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.中国山东省基于人群的广泛耐药结核病监测。

Int J Tuberc Lung Dis. 2012 May;16(5):612-4. doi: 10.5588/ijtld.11.0507. Epub 2012 Mar 7.

5

Drug-resistant tuberculosis: reality and potential threat.耐药结核病：现状与潜在威胁

Int J Tuberc Lung Dis. 2010 Mar;14(3):255-8.

6

Fluoroquinolone-resistant Mycobacterium tuberculosis, Pakistan, 2005-2009.2005 - 2009年，巴基斯坦耐氟喹诺酮结核分枝杆菌

Emerg Infect Dis. 2011 Mar;17(3):564-6. doi: 10.3201/eid1703.100957.

7

Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.耐多药结核分枝杆菌在结核病转诊中心的尼泊尔患者中。

PLoS One. 2024 May 6;19(5):e0301210. doi: 10.1371/journal.pone.0301210. eCollection 2024.

8

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.高氟喹诺酮耐药比例在孟买大都市区由主导 L2 结核分枝杆菌克隆驱动的耐多药结核病中。

Genome Med. 2022 Aug 22;14(1):95. doi: 10.1186/s13073-022-01076-0.

9

Resistance to anti-tuberculosis medications in the Horn of Africa.非洲之角的抗结核药物耐药性。

Int J Tuberc Lung Dis. 2011 Mar;15(3):414-6.

10

Fluoroquinolone resistance in multidrug-resistant independent of fluoroquinolone use.耐多药中的氟喹诺酮耐药性与氟喹诺酮的使用无关。

Eur Respir J. 2017 Dec 7;50(6). doi: 10.1183/13993003.01633-2017. Print 2017 Dec.

引用本文的文献

1

Experience on the first national anti-TB drug resistance survey (DRS) in Timor-Leste.在东帝汶进行的第一次全国抗结核药物耐药性调查（DRS）的经验。

Glob Health Res Policy. 2022 May 20;7(1):16. doi: 10.1186/s41256-022-00249-z.

2

Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.结核患者异烟肼耐药的流行情况和基因谱：跨国分析的横断面数据。

PLoS Med. 2020 Jan 21;17(1):e1003008. doi: 10.1371/journal.pmed.1003008. eCollection 2020 Jan.

3

Clinical Impact of Rapid Drug Susceptibility Testing to Accompany Fluoroquinolone-Containing Universal Tuberculosis Regimens: A Markov Model.